European Medical Solutions (STU:AS00) DeferredTaxAndRevenue: €0.00 Mil (As of Dec. 2025)


STU:AS00 European Medical Solutions STU:AS00
43 GF Score
Price €3.98
GF Value €8.16
! 2 Warning Signs
View Full Analysis

What is European Medical Solutions DeferredTaxAndRevenue?

European Medical Solutions STU:AS00 -7.87% 43 DeferredTaxAndRevenue is €0.00 Mil as of Dec. 2025. GuruFocus rates STU:AS00 with a GF Score™ of 43/100 and a GF Value™ of €8.16. The stock has 2 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

European Medical Solutions's current deferred tax and revenue for the quarter that ended in Dec. 2025 was €0.00 Mil.

European Medical Solutions DeferredTaxAndRevenue Related Terms

European Medical Solutions DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for European Medical Solutions's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

European Medical Solutions DeferredTaxAndRevenue Chart

European Medical Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

European Medical Solutions Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:AS00
43GF Score
European Medical Solutions STU:AS00
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of €0.00 Mil mean?
European Medical Solutions (STU:AS00) has a DeferredTaxAndRevenue of €0.00 Mil as of Dec. 2025. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on European Medical Solutions.
Is European Medical Solutions' DeferredTaxAndRevenue too high?
European Medical Solutions' current DeferredTaxAndRevenue is €0.00 Mil. Overall, European Medical Solutions has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' DeferredTaxAndRevenue compare to VRTX and REGN?
European Medical Solutions' DeferredTaxAndRevenue of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Biotechnology company?
A good DeferredTaxAndRevenue depends on the Biotechnology industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on European Medical Solutions. European Medical Solutions's current DeferredTaxAndRevenue is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
European Medical Solutions (STU:AS00) has a current DeferredTaxAndRevenue of €0.00 Mil. The stock's GF Value™ is €8.16, compared to a current price of €3.98 — trading 51.2% below its estimated fair value. The current DeferredTaxAndRevenue is €0.00 Mil. European Medical Solutions' overall GF Score™ is 43/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current DeferredTaxAndRevenue is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is European Medical Solutions (STU:AS00) Overvalued in 2026?

Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued. The current stock price of €3.98 is trading 51.2% below its estimated GF Value™ of €8.16.

Key valuation signals for STU:AS00:

  • DeferredTaxAndRevenue: €0.00 Mil
  • GF Value™: €8.16 vs. price of €3.98 (51.2% below fair value)
  • GF Score™: 43/100 with 2 warning signs

No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

European Medical Solutions Business Description

Other Exchanges ALEMS:Belgium
Address 7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
43GF Score

Get the complete analysis for STU:AS00

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.98
Price
€8.16
GF Value